| Gamma delta tocotrienols reduce hepatic triglyceride synthesis and VLDL secretion. | |
| | |
MedLine Citation:
|
PMID: 20702976 Owner: NLM Status: In-Process |
Abstract/OtherAbstract:
|
AIM: Present study aimed to elucidate the suppression of serum lipids by gamma- and delta-tocotrienol (γδT3). METHODS: The lipid-lowering effects of γδT3 were investigated using HepG2 liver cell line, hypercholesterolemic mice and borderline-high cholesterol patients. RESULTS: In-vitro results demonstrated two modes of action. First, γδT3 suppressed the upstream regulators of lipid homeostasis genes (DGAT2, APOB100, SREBP1/2 and HMGCR) leading to the suppression of triglycerides, cholesterol and VLDL biosyntheses. Second, γδT3 enhanced LDL efflux through induction of LDL receptor (LDLr) expression. Treatment of LDLr-deficient mice with 1 mg/day (50 mg/kg/day) γδT3 for one-month showed 28%, 19% reduction in cholesterol and triglyceride levels respectively, whereas HDL level was unaltered. The lipid-lowering effects were not affected by alpha-tocopherol (αTP). In a placebo-controlled human trial using 120 mg/day γδT3, only serum triglycerides were lowered by 28% followed by concomitant reduction in the triglyceride-rich VLDL and chylomicrons. In contrast, total cholesterol, LDL and HDL remained unchanged in treated and placebo groups. The discrepancies between in-vitro, in-vivo and human studies may be attributed to the differential rates of post-absorptive γδT3 degradation and LDL metabolism. CONCLUSION: Reduction in triglycerides synthesis and transport may be the primary benefit caused by ingesting γδT3 in human. |
| | |
Authors:
|
N Zaiden; W N Yap; S Ong; C H Xu; V H Teo; C P Chang; X W Zhang; K Nesaretnam; S Shiba; Y L Yap |
Related Documents
:
|
199396 - The passage of apoproteins from plasma lipoproteins into the lipoproteins of peripheral... 3887526 - Lipid transport systems: some recent aspects in swine, cattle and trout during developm... 6227506 - High-dose depot-medroxyprogesterone acetate (dmpa) - effects on lipid and lipoprotein m... 7698516 - Effect of treatment with a hydroxymethylglutaryl coenzyme a reductase inhibitor on fast... 22294316 - Oxidant damage in kashin-beck disease and a rat kashin-beck disease model by employing ... 19258386 - Better preservation of residual renal function in peritoneal dialysis patients treated ... |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't Date: 2010-08-10 |
Journal Detail:
|
Title: Journal of atherosclerosis and thrombosis Volume: 17 ISSN: 1880-3873 ISO Abbreviation: J. Atheroscler. Thromb. Publication Date: 2010 Oct |
Date Detail:
|
Created Date: 2010-11-02 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9506298 Medline TA: J Atheroscler Thromb Country: Japan |
Other Details:
|
Languages: eng Pagination: 1019-32 Citation Subset: IM |
Affiliation:
|
Davos Life Science Pte Ltd, Cardiovascular Research Laboratory Singapore, 16 Tuas South Street 5, Singapore. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Impairment of the vasodilatation capability of the brachial artery in patients with idiopathic venou...
Next Document: [Analysis of radioactivation induced by high-energy X-rays in medical linear accelerators -estimatio...